Bundled Payments with Drug Costs Threaten Cancer Care Quality

According to a new report in the Journal of Oncology Practice, bundled payment models do not incentivize quality. Practices treating less complex and higher volume patients would receive a higher reimbursement, where practices treating more complex and a smaller number of patients would see a decrease in reimbursement.

Source: https://revcycleintelligence.com/news/bundled-payments-with-drug-costs-threaten-cancer-care-quality